Personalised Cancer Medicine Flashcards 2025


Standard

Recommended

Currently not recommended
- HER2
- Microsatellite Instability*
- PDL-1
- VEGFR
- EGFR
- MET
- EBV
The Recommended category is based on currentrecommendations by EMEA and FDA.
References:
1. Alsina Maqueda M, Teijo Quintáns A, Cuatrecasas M, Fernández Aceñero MJ, Fernández Montes A, Gómez Martín C, Jiménez Fonseca P, Martínez Ciarpaglini C, Rivera Herrero F, Iglesias Coma M. Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP). Clin Transl Oncol. 2025 Mar 12. doi: 10.1007/s12094-025-03865-6.
2. Shitara K, Fleitas T, Kawakami H, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer. ESMO Open. 2024;9(2):102226. doi:10.1016/j.esmoop.2023.102226.